These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 16815524)

  • 1. Hexamethylene amiloride blocks E protein ion channels and inhibits coronavirus replication.
    Wilson L; Gage P; Ewart G
    Virology; 2006 Sep; 353(2):294-306. PubMed ID: 16815524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure and inhibition of the SARS coronavirus envelope protein ion channel.
    Pervushin K; Tan E; Parthasarathy K; Lin X; Jiang FL; Yu D; Vararattanavech A; Soong TW; Liu DX; Torres J
    PLoS Pathog; 2009 Jul; 5(7):e1000511. PubMed ID: 19593379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effects of viroporin inhibitors against feline infectious peritonitis virus serotypes I and II.
    Takano T; Nakano K; Doki T; Hohdatsu T
    Arch Virol; 2015 May; 160(5):1163-70. PubMed ID: 25701212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of coronavirus E proteins ion channels as targets for antiviral drugs.
    Wilson L; Gage P; Ewart G
    Adv Exp Med Biol; 2006; 581():573-8. PubMed ID: 17037600
    [No Abstract]   [Full Text] [Related]  

  • 5. Cation-selective ion channels formed by p7 of hepatitis C virus are blocked by hexamethylene amiloride.
    Premkumar A; Wilson L; Ewart GD; Gage PW
    FEBS Lett; 2004 Jan; 557(1-3):99-103. PubMed ID: 14741348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amiloride derivatives block ion channel activity and enhancement of virus-like particle budding caused by HIV-1 protein Vpu.
    Ewart GD; Mills K; Cox GB; Gage PW
    Eur Biophys J; 2002 Mar; 31(1):26-35. PubMed ID: 12046895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In Silico Evaluation of Hexamethylene Amiloride Derivatives as Potential Luminal Inhibitors of SARS-CoV-2 E Protein.
    Jalily PH; Jalily Hasani H; Fedida D
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Probing interactions of Vpu from HIV-1 with amiloride-based compounds.
    Rosenberg MR; Weaver LM; Casarotto MG
    Biochim Biophys Acta; 2016 Apr; 1858(4):733-9. PubMed ID: 26724207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amantadine inhibits the function of an ion channel encoded by GB virus B, but fails to inhibit virus replication.
    Premkumar A; Dong X; Haqshenas G; Gage PW; Gowans EJ
    Antivir Ther; 2006; 11(3):289-95. PubMed ID: 16759044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARS coronavirus E protein forms cation-selective ion channels.
    Wilson L; McKinlay C; Gage P; Ewart G
    Virology; 2004 Dec; 330(1):322-31. PubMed ID: 15527857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phillyrin (KD-1) exerts anti-viral and anti-inflammatory activities against novel coronavirus (SARS-CoV-2) and human coronavirus 229E (HCoV-229E) by suppressing the nuclear factor kappa B (NF-κB) signaling pathway.
    Ma Q; Li R; Pan W; Huang W; Liu B; Xie Y; Wang Z; Li C; Jiang H; Huang J; Shi Y; Dai J; Zheng K; Li X; Hui M; Fu L; Yang Z
    Phytomedicine; 2020 Nov; 78():153296. PubMed ID: 32890913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coronavirus E protein forms ion channels with functionally and structurally-involved membrane lipids.
    Verdiá-Báguena C; Nieto-Torres JL; Alcaraz A; DeDiego ML; Torres J; Aguilella VM; Enjuanes L
    Virology; 2012 Oct; 432(2):485-94. PubMed ID: 22832120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amantadine has potential for the treatment of COVID-19 because it inhibits known and novel ion channels encoded by SARS-CoV-2.
    Toft-Bertelsen TL; Jeppesen MG; Tzortzini E; Xue K; Giller K; Becker S; Mujezinovic A; Bentzen BH; B Andreas L; Kolocouris A; Kledal TN; Rosenkilde MM
    Commun Biol; 2021 Dec; 4(1):1347. PubMed ID: 34853399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of the coronavirus E viroporin protein transmembrane domain in virus assembly.
    Ye Y; Hogue BG
    J Virol; 2007 Apr; 81(7):3597-607. PubMed ID: 17229680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Properties of Coronavirus and SARS-CoV-2.
    Malik YA
    Malays J Pathol; 2020 Apr; 42(1):3-11. PubMed ID: 32342926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of Action of Novel Influenza A/M2 Viroporin Inhibitors Derived from Hexamethylene Amiloride.
    Jalily PH; Eldstrom J; Miller SC; Kwan DC; Tai SS; Chou D; Niikura M; Tietjen I; Fedida D
    Mol Pharmacol; 2016 Aug; 90(2):80-95. PubMed ID: 27193582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Infectious Bronchitis Coronavirus Envelope Protein Alters Golgi pH To Protect the Spike Protein and Promote the Release of Infectious Virus.
    Westerbeck JW; Machamer CE
    J Virol; 2019 Jun; 93(11):. PubMed ID: 30867314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions of SARS-CoV-2 envelope protein with amilorides correlate with antiviral activity.
    Park SH; Siddiqi H; Castro DV; De Angelis AA; Oom AL; Stoneham CA; Lewinski MK; Clark AE; Croker BA; Carlin AF; Guatelli J; Opella SJ
    PLoS Pathog; 2021 May; 17(5):e1009519. PubMed ID: 34003853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coronavirus genome structure and replication.
    Brian DA; Baric RS
    Curr Top Microbiol Immunol; 2005; 287():1-30. PubMed ID: 15609507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro virucidal activity of Echinaforce®, an Echinacea purpurea preparation, against coronaviruses, including common cold coronavirus 229E and SARS-CoV-2.
    Signer J; Jonsdottir HR; Albrich WC; Strasser M; Züst R; Ryter S; Ackermann-Gäumann R; Lenz N; Siegrist D; Suter A; Schoop R; Engler OB
    Virol J; 2020 Sep; 17(1):136. PubMed ID: 32907596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.